MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
27.40
-1.80 (-6.16%)
At close: May 8, 2026, 4:00 PM EDT
27.27
-0.13 (-0.48%)
After-hours: May 8, 2026, 6:54 PM EDT
MapLight Therapeutics Employees
MapLight Therapeutics had 133 employees as of December 31, 2025. The number of employees increased by 70 or 111.11% compared to the previous year.
Employees
133
Change
70
Growth
111.11%
Revenue / Employee
n/a
Profits / Employee
-$1,211,669
Market Cap
1.24B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 133 | 30 | 29.13% |
| Sep 30, 2025 | 114 | - | - |
| Jun 30, 2025 | 109 | 35 | 47.30% |
| Mar 31, 2025 | 103 | 29 | 39.19% |
| Mar 31, 2024 | 74 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Maravai LifeSciences Holdings | 435 |
| EyePoint | 214 |
| Zenas BioPharma | 167 |
| Olema Pharmaceuticals | 131 |
| MoonLake Immunotherapeutics | 130 |
| DBV Technologies | 117 |
| GH Research | 73 |
| Savara | 70 |
MPLT News
- 1 day ago - MapLight Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 days ago - MapLight Therapeutics initiated with a Buy at H.C. Wainwright - TheFly
- 8 days ago - MapLight Therapeutics completes enrollment in ZEPHYR trial - TheFly
- 8 days ago - MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results - GlobeNewsWire
- 4 weeks ago - MapLight Therapeutics initiated with a Buy at Needham - TheFly
- 4 weeks ago - MapLight Therapeutics initiated with a Buy at TD Cowen - TheFly
- 6 weeks ago - MapLight Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 7 weeks ago - Canaccord starts MapLight with Buy into schizophrenia data - TheFly